Stefan Schreiber

29PUBLICATIONS
147CO-AUTHORS
Nutrigenomics and personalised nutritionGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples diet and nutritionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 01, 2026
A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBD.

|May 29, 2026
Large-scale analysis of temporal gene expression variation in peripheral blood.

|Mar 30, 2026
Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial.

Stefan Schreiber, Bruce E Sands, Silvio Danese

|Mar 28, 2026
IL-22 induces Paneth cell metaplasia in the colonic epithelium of ulcerative colitis, promoting wound healing via REG3A.

Tomohiro Muto, Go Ito, Hiromune Katsuda

|Mar 25, 2026
Pharmacokinetics and efficacy of subcutaneous infliximab 120 mg every 2 weeks: a post hoc comparison with intravenous dosing in a phase 1 study in patients with inflammatory bowel disease.

Stefan Schreiber, Byong Duk Ye, Hyunseong Yu

|Mar 18, 2026
Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials.

Marla C Dubinsky, Stefan Schreiber, Andres J Yarur

Pageof 5

Frequent Collaborators

6 joint publications

Silvio Danese

6 joint publications

Philip Rosenstiel

5 joint publications

Andre Franke

4 joint publications

Jean-Frederic Colombel